In8Bio (INAB) Interest & Investment Income (2024 - 2026)
In8Bio (INAB) posted Interest & Investment Income of $176000.0 for Q1 2026, up 93.41% sequentially from $91000.0 in Q4 2025, and up 60.0% YoY from $110000.0 in Q1 2025.
In8Bio (INAB) Interest & Investment Income (2024 - 2026) Analysis & Trends
In8Bio has reported Interest & Investment Income for 3 years, with the latest figure at $176000.0 in Q1 2026.
- Quarterly Interest & Investment Income rose 60.0% year-over-year to $176000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $487000.0 (up 89.49% YoY) and the FY2025 annual result came in at $421000.0, up 83.04% from the prior year.
- Interest & Investment Income rose to $176000.0 in Q1 2026 per INAB's latest filing, from $91000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $176000.0 in Q1 2026 and troughed at $23000.0 in Q3 2024.
- A 3-year average of $91888.9 and a median of $91000.0 in 2025 frame the typical range for Interest & Investment Income.
- The widest YoY moves for Interest & Investment Income: up 391.3% in 2025, down 32.53% in 2025.
- Over 3 years, Interest & Investment Income stood at $64000.0 in 2024, then surged by 42.19% to $91000.0 in 2025, then soared by 93.41% to $176000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $176000.0, $91000.0, and $113000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | In8Bio | 24.34 Mn | 24.34 Mn | - | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 154,000.00 |
| Mar 31, 2026 | 176,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Jun 30, 2025 | 107,000.00 |
| Mar 31, 2025 | 110,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Mar 31, 2024 | 83,000.00 |